mascc.org

Home [www.mascc.org]
Welcome to MASCC Leading supportive care in the 21st century. Supportive Care in cancer is the prevention and management of the adverse effects of cancer and its ... Mid Atlantic Systems
Mid Atlantic Systems bring high level technical support with expertise in computer networks, upgrades, consulting, cabling, internet services, and programming, and ... 2012 Symposium
Kenes International 1-3, Rue de Chantepoulet, P.O. Box 1726 CH-1211 Geneva 1 Switzerland Tel: +41 22 908 0488 Fax: +41 22 906 9140 E-mail: mascc@kenes.com Cancer Care Symposium - MASCC/ISOO 2012, New York
The MASCC/ISOO International Symposium on Supportive Care will take place in New York from 28-30 June, 2012. A.P. Pharma to Present APF530 Patient-Satisfaction Data from Phase ...
The full abstract is available on the MASCC/ISOO website, here. About APF530. A.P. Pharma's lead product, APF530, is in development for the prevention of both ... Cancer Care Symposium - Registration - Kenes International Error Page
Register for MASCC/ISOO 2012, New York ... On line registration will be available until June 24, 2012. REGISTRATION DESKS Mid Atlantic Systems
Mid Atlantic Systems bring high level technical support to small businesses with expertise in computer networks, upgrades, cabling, internet services, and programming ... Calculate Risk in Febrile Neutropenia (MASCC) | QxMD Medical Apps
Online calculator of Risk in Febrile Neutropenia with free download to iPhone, BlackBerry and Android. MASCC/ISOO 2012 International Symposium
The MASCC/ISOO 2012 Symposium will bring together healthcare professionals in the field of supportive care in cancer, in an excellent forum to share ideas and ... MASCC Index Score for Identifying Low-Risk Febrile Neutropenic ...
Advertisement. The content of this website is provided for general informational purposes only and is not a substitute professional medical advice

Podium and Poster Presentations To Be Given On Interim Data From MuGard Phase IV Trial
The Multinational Association of Supportive Care in Cancer (MASCC) is the leading international organization dedicated to the research and education in all aspects of supportive care for patients with cancer.  It joined forces with the International ... GTx announces presentations on enobosarm
at the MASCC/ISOO 2012 International Symposium. James T. Dalton, PhD., VP, Chief Scientific Officer of GTx, will present data from the company’s Phase IIb clinical study of enobosarm providing evidence that enobosarm may play an important role ... A.P. Pharma To Present APF530 Patient-Satisfaction Data From Phase 3 Study
The MASCC/ISOO 2012 International Symposium focuses on the clinical management of supportive care in oncology and will be held in New York City June 28 – 30. APF530 is the Company’s lead product candidate being developed for the prevention ... GTx Announces Panel Presentation On Muscle Wasting In Non-Small Cell Lung Cancer Patients
GTx, Inc. (GTXI) announced today that it is sponsoring at the MASCC/ISOO 2012 International Symposium, a panel presentation on “Muscle Wasting in Non-Small Cell Lung Cancer Patients: A New Scientific Approach to Management.” The panel ... New Developments in Management of Oral Mucositis in Patients With Head and Neck Cancer or Receiving Targeted Anticancer Therapies
For example, "magic mouthwash" preparations (various mouth rinse formulations containing topical anesthetics and antiinflammatory agents) are not recommended in the MASCC–ISOO guidelines or the ONS review, but they were mentioned as useful ...